InvestorsHub Logo
Followers 63
Posts 7608
Boards Moderated 1
Alias Born 01/02/2003

Re: rosemountbomber post# 375672

Wednesday, 04/27/2022 1:02:46 PM

Wednesday, April 27, 2022 1:02:46 PM

Post# of 429367
Rose..." the caveat is if there is some fundamental change to what we are experiencing now, then anything could be possible."

The fundamental change I am awaiting is the FDA approval of a once daily statin-MD2119(EPA) combo to restore our patents for the US market.

With that in mind, I would hope that Amarin immediately directs its time, energy and assets towards effecting the approval of that product...while we continue to grow our market for Vascepa in Europe and also grow our market slightly in the US.

I am also awaiting Vascepa approval in China....We need to negotiate with Eddingpharm and with Chinese regulatory agencies to make that happen.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News